Literature DB >> 24662746

Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition.

Yifeng Jing1, Di Cui1, Wenhuan Guo2, Juntao Jiang1, Bo Jiang1, Youyi Lu1, Wei Zhao1, Xiaohai Wang1, Qi Jiang1, Bangmin Han3, Shujie Xia4.   

Abstract

Androgen receptor (AR) has been indicated to be involved in bladder cancer progression. We showed androgen induced epithelial-mesenchymal transition (EMT) in AR-positive bladder cancer cells and promoted tumor metastasis in xenograft models. We subsequently identified that Slug was the mediator of EMT induced by androgen. Furthermore, upregulation of Slug was due to activation of Wnt/β-catenin signaling in response to androgen. Finally, expression of AR showed strong correlation with loss of E-cadherin, higher expression of Slug and nuclear accumulation of β-catenin in bladder tumor tissues. Taken together, our results suggest AR signaling promotes bladder cancer metastasis through Slug mediated EMT.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Androgen receptor; Bladder cancer; Epithelial-mesenchymal transition; Slug

Mesh:

Substances:

Year:  2014        PMID: 24662746     DOI: 10.1016/j.canlet.2014.03.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  45 in total

1.  Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract.

Authors:  Eiji Kashiwagi; Kazutoshi Fujita; Seiji Yamaguchi; Hiroaki Fushimi; Hiroki Ide; Satoshi Inoue; Taichi Mizushima; Leonardo O Reis; Rajni Sharma; George J Netto; Norio Nonomura; Hiroshi Miyamoto
Journal:  Cancer Biol Ther       Date:  2016-09-16       Impact factor: 4.742

2.  Expression and clinical significance of androgen receptor in bladder cancer: A meta-analysis.

Authors:  Jinbo Chen; Yu Cui; Peng Li; Longfei Liu; Chao Li; Xiongbing Zu
Journal:  Mol Clin Oncol       Date:  2017-08-23

Review 3.  The route to personalized medicine in bladder cancer: where do we stand?

Authors:  Francesco Massari; Chiara Ciccarese; Matteo Santoni; Matteo Brunelli; Alessandro Conti; Alessandra Modena; Rodolfo Montironi; Daniele Santini; Liang Cheng; Guido Martignoni; Stefano Cascinu; Giampaolo Tortora
Journal:  Target Oncol       Date:  2015-01-30       Impact factor: 4.493

4.  Notch signaling induces epithelial-mesenchymal transition to promote invasion and metastasis in adenoid cystic carcinoma.

Authors:  Zhi-Li Zhao; Si-Rui Ma; Wei-Ming Wang; Cong-Fa Huang; Guang-Tao Yu; Tian-Fu Wu; Lin-Lin Bu; Yu-Fan Wang; Yi-Fang Zhao; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

Review 5.  Gender differences in incidence and outcomes of urothelial and kidney cancer.

Authors:  Ilaria Lucca; Tobias Klatte; Harun Fajkovic; Michela de Martino; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2015-10       Impact factor: 14.432

6.  Androgen receptor (AR) promotes male bladder cancer cell proliferation and migration via regulating CD24 and VEGF.

Authors:  Guoqing Ding; Shicheng Yu; Sheng Cheng; Gonghui Li; Yanlan Yu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

7.  Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy.

Authors:  Christian Thomas; Alexander Giesswein; Michael Hainz; Raimund Stein; Peter Rubenwolf; Frederik C Roos; Andreas Neisius; Sebastian Nestler; Christian Hampel; Wolfgang Jäger; Christoph Wiesner; Joachim W Thüroff
Journal:  Int Urol Nephrol       Date:  2015-09-16       Impact factor: 2.370

8.  Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals.

Authors:  Le Tao; Jianxin Qiu; Ming Jiang; Wenbin Song; Shuyuan Yeh; Hong Yu; Lijuan Zang; Shujie Xia; Chawnshang Chang
Journal:  Mol Cancer Ther       Date:  2016-05-11       Impact factor: 6.261

9.  The effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancer.

Authors:  Zaixian Zhang; Qingquan Xu; Xiaobo Huang; Jia Yang; Yanhong Xu; Guixiang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.

Authors:  Yichun Zheng; Hitoshi Ishiguro; Hiroki Ide; Satoshi Inoue; Eiji Kashiwagi; Takashi Kawahara; Mehrsa Jalalizadeh; Leonardo O Reis; Hiroshi Miyamoto
Journal:  Mol Endocrinol       Date:  2015-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.